- Investing Ideas
- /
- Swedish Pharmaceuticals & Biotech Net Cash Stocks With A Growth Track Record
Swedish Pharmaceuticals & Biotech Net Cash Stocks With A Growth Track Record
Results
4
These companies have grown profits at a double digit rate for 5 years or more. And they have net cash.
4 companies
Camurus
Market Cap: SEK 43.1b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 724.50
7D
0.6%
1Y
7.6%
Bonesupport Holding
Market Cap: SEK 21.0b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 318.40
7D
2.6%
1Y
10.2%
BioGaia
Market Cap: SEK 10.5b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 104.10
7D
-0.8%
1Y
-10.6%
Genovis AB (publ.)
Market Cap: SEK 1.5b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 23.00
7D
-3.6%
1Y
-1.9%